Commonwealth Equity Services LLC lifted its position in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 5.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 43,927 shares of the company’s stock after acquiring an additional 2,365 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Perrigo were worth $1,129,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. Versant Capital Management Inc bought a new position in shares of Perrigo in the 4th quarter worth about $45,000. GAMMA Investing LLC lifted its holdings in Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock worth $49,000 after acquiring an additional 929 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after acquiring an additional 500 shares during the period. Venturi Wealth Management LLC grew its holdings in shares of Perrigo by 97.8% during the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company’s stock valued at $108,000 after purchasing an additional 2,084 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Perrigo during the 4th quarter worth approximately $149,000. Institutional investors and hedge funds own 95.91% of the company’s stock.
Perrigo Stock Up 0.0 %
PRGO opened at $28.07 on Tuesday. The stock’s 50 day moving average price is $26.19 and its 200 day moving average price is $26.16. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The stock has a market cap of $3.83 billion, a P/E ratio of -23.99 and a beta of 0.48. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.46.
Perrigo Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were paid a $0.29 dividend. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.13%. The ex-dividend date of this dividend was Friday, March 7th. Perrigo’s dividend payout ratio is currently -92.80%.
Analyst Ratings Changes
A number of research analysts recently issued reports on the company. StockNews.com lowered Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Argus downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Finally, Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $34.00 to $27.00 in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $33.00.
Read Our Latest Analysis on Perrigo
Insider Activity
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares of the company’s stock, valued at approximately $923,795.04. This trade represents a 18.81 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.70% of the company’s stock.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Recommended Stories
- Five stocks we like better than Perrigo
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- 3 Healthcare Dividend Stocks to Buy
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.